Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Influenza
Sort By
Newest First
1 / 2
1 / 2
Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus and Influenza Vaccines
Osivax
PR-M07-20-NI-010
Jul 09, 2020
Immunotherapy
Applying the Principles of Immunotherapy to Infectious Diseases
Jeffrey Stein, Ph.D.
Cidara Therapeutics
PAP-Q2-20-CL-018
Jul 01, 2020
H1N1
Seaweed Extract Reduces Flu Severity
Marinova
PR-M05-20-NI-018-1563
May 12, 2020
Influenza
Bloomfield Hills Teen Awarded $25,000 for Developing Method to Create Universal Influenza Vaccine
Davidson Institute
PR-M08-19-NI-060
Aug 21, 2019
Influenza
Sanofi Signs Strategic Deal for Exclusive US Over-the-Counter Rights to Tamiflu® in Flu Care
Sanofi
PR-M07-19-NI-061
Jul 24, 2019
Influenza
Genentech’s Xofluza Flu Treatment Effective in Children
Emilie Branch
Pharma's Almanac
PAO-M07-19-NI-019
Jul 22, 2019
Influenza
GSK Ships 2019-20 Seasonal Influenza Vaccines for US Market
Nice Insight
PR-M07-19-NI-047-2363
Jul 19, 2019
Vaccines
Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains
Moderna
PR-M05-19-NI-041
May 14, 2019
FDA Approval
Genentech Receives FDA Approval for Flu Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-001
Nov 05, 2018
Influenza
Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
Abbott
PR-M10-18-NI-099
Oct 29, 2018
Influenza
Cell-Based Flu Vaccines Appear to Be More Effective than Egg-Based Strains
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M10-18-NI-017
Oct 22, 2018
Influenza
FluMist Shipped by AstraZeneca
Nice Insight
PAO-M10-18-NI-007-3592
Oct 04, 2018
Collaboration
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza
BioNTech
PR-M09-18-NI-052
Sep 18, 2018
Vaccines
GSK Ships 2018-19 Seasonal Influenza Vaccines for US Market
GSK Contract Manufacturing
PR-M08-18-NI-110
Aug 29, 2018
Influenza
Brexit Issues Could Impact Flu Shot Deliveries to the UK
Nice Insight
PAO-M08-18-NI-022
Aug 22, 2018
Influenza
Anti-Flu Drug Exploits Weakness in H3N2 Strain
Emilie Branch
Pharma's Almanac
PAO-M03-18-NI-021
Mar 23, 2018
Influenza
New BI Vaccine Allows Very Early Vaccination of Piglets Against Swine Flu
Nigel Walker
Nice Insight
PAO-M03-18-NI-010
Mar 09, 2018
Influenza
GSK presents new efficacy data for FLUARIX® QUADRIVALENT (Influenza Vaccine) in children 6 months through 35 months of age
GSK
PR-M02-18-NI-87
Feb 23, 2018
Vaccine
GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older
Glaxosmithkline
PR-M01-18-NI-046
Jan 17, 2018
Capacity Expansion
Sanofi Expanding Manufacturing Capacity for Quadrivalent Influenza Vaccine
Guy Tiene
Nice Insight
PAO-M10-17-NI-043
Oct 26, 2017
